AYUSH-64 is an Ayurvedic formulation which was developed by the Central Council forResearch in Ayurvedic Sciences (CCRAS), the apex body for research in Ayurveda underthe Ministry of Ayush, for management of Malaria. This drug was repurposed as theingredients showed notable antiviral, immune-modulator and antipyretic properties. Thein-silico study done on AYUSH-64 showed that about 35 out of 36 of its Phyto-constituentshave high binding affinity against COVID 19 virus. The formulation has also shown verypromising results in Influenza like illness. With the scientific evidence generated from 06 clinical studies across India, AYUSH-64 has been identified as a potential adjunct tostandard care in the management of asymptomatic, mild and moderate COVID-19 toimprove the clinical recovery and quality of life.
DOSAGE : The dose for asymptomatic COVID-19 case is 2 tablets of 500 mg twice daily one hour after meals with warm water for 14 days. The dose for mild to moderate cases is 2 tablets of 500 mg thrice daily one hour after meals with warm water for 14 days
It can be taken with warm water, preferably one hour after the food.